| 4-HNE | 4-hydroxynonenal |
| 8-OHdG | 8-hydroxy-2′-deoxyguanosine |
| 8-OHG | 8-hydroxyguanosine |
| 8-oxodG | 8-oxo-7,8-dihydro-2′-deoxyguanosine |
| ACSL4 | acyl-CoA synthetase long-chain family member 4 |
| AI | artificial intelligence |
| AOPP | advanced oxidation protein products |
| ARE | antioxidant response element |
| AUC | area under the curve |
| BCR-ABL | breakpoint cluster region–Abelson tyrosine kinase |
| BMI | body mass index |
| CAFs | cancer-associated fibroblasts |
| CAT | catalase |
| CEA | carcinoembryonic antigen |
| CFIR | Consolidated Framework for Implementation Research |
| CLIA | Clinical Laboratory Improvement Amendments |
| CRC | colorectal cancer |
| DNA | deoxyribonucleic acid |
| DNMTs | DNA methyltransferases |
| ECM | extracellular matrix |
| ELISA | enzyme-linked immunosorbent assay |
| EMT | epithelial-to-mesenchymal transition |
| ERK | extracellular signal-regulated kinase |
| FH | fumarate hydratase |
| FRAP | ferric reducing antioxidant power |
| GLP | Good Laboratory Practice |
| GPx | glutathione peroxidase |
| GSH | reduced glutathione |
| GSH-Px | glutathione peroxidase |
| GSSG | oxidized glutathione |
| HER2 | human epidermal growth factor receptor 2 |
| HIF-1 | hypoxia-inducible factor 1 |
| HPLC | high-performance liquid chromatography |
| HTA | health technology assessment |
| IAPs | inhibitors of apoptosis proteins |
| iNOS | inducible nitric oxide synthase |
| ISO | International Organization for Standardization |
| KEAP1 | Kelch-like ECH-associated protein 1 |
| LDL | low-density lipoprotein |
| LPCAT3 | lysophosphatidylcholine acyltransferase 3 |
| LPO | lipid peroxidation |
| MAPK | mitogen-activated protein kinase |
| MDA | malondialdehyde |
| MMP | matrix metalloproteinase |
| MPO | myeloperoxidase |
| NADPH | nicotinamide adenine dinucleotide phosphate |
| NF-κB | nuclear factor kappa B |
| NOX | NADPH oxidase |
| NRF2 | nuclear factor erythroid 2-related factor 2 |
| NSCLC | non-small cell lung cancer |
| OS | oxidative stress |
| OSCC | oral squamous cell carcinoma |
| PBMC | peripheral blood mononuclear cell |
| PD-1 | programmed cell death protein 1 |
| PD-L1 | programmed death-ligand 1 |
| PI3K | phosphoinositide 3-kinase |
| PON1 | paraoxonase 1 |
| PTEN | phosphatase and tensin homolog |
| PUFAs | polyunsaturated fatty acids |
| QA | quality assurance |
| QALY | quality-adjusted life year |
| QC | quality control |
| RCC | renal cell carcinoma |
| RNS | reactive nitrogen species |
| ROS | reactive oxygen species |
| SDH | succinate dehydrogenase |
| SIRT3 | sirtuin 3 |
| SOD | superoxide dismutase |
| TAC | total antioxidant capacity |
| TME | tumor microenvironment |
| TNM | tumor–node–metastasis |
| VEGF | vascular endothelial growth factor |
| XO | xanthine oxidase |